scispace - formally typeset
H

Hiromi Mochizuki

Researcher at National Institute of Advanced Industrial Science and Technology

Publications -  9
Citations -  600

Hiromi Mochizuki is an academic researcher from National Institute of Advanced Industrial Science and Technology. The author has contributed to research in topics: Induced pluripotent stem cell & Somatic cell. The author has an hindex of 5, co-authored 9 publications receiving 564 citations.

Papers
More filters
Journal ArticleDOI

Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1

TL;DR: DNA microarray analyses show that Glis1 effectively promotes the direct reprogramming of somatic cells during iPSC generation, including Myc, Nanog, Lin28, Wnt, Essrb and the mesenchymal–epithelial transition.
Patent

Method of efficiently establishing induced pluripotent stem cells

TL;DR: In this article, a method of improving iPS cell establishment efficiency, comprising the step of transferring Lin28B or a nucleic acid that encodes Lin28 B to a somatic cell, particularly to a soma cell on which Lin28 is ineffective or less effective than Lin28b in improving the establishment efficiency of iPS cells.
Journal ArticleDOI

Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures.

TL;DR: It is found that overexpression of retinoic acid receptor α (RARA) disrupted normal acinar structure and induced epithelial‐to‐mesenchymal transition (EMT) and the mRNA levels of known EMT‐inducing factors, including SLUG, FOXC2, ZEB1, and ZEB2, were significantly increased upon RARA overeexpression.
Journal ArticleDOI

Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene.

TL;DR: An integrated analysis system of amplicons is established using retrovirus‐mediated gene transfer coupled with a human full‐length cDNA set, and GRB7 is identified as a context‐dependent oncogene, which modulates the ERBB2 signaling pathway through enhanced phosphorylation of ER BB2 and Akt.